Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Certain drugs that block specific enzymes can help treat prostate diseases.

Finasteride effectively treats BPH, but needs more trials to understand potential.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

High doses of cyclosporine A increase testosterone conversion, possibly boosting hair growth.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Androgens don't directly affect hair cell growth or protein production.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.